NCT02190656

Brief Summary

Bowel cancer is the third most common cancer in the UK in both males and females. The rectum is the most commonly affected part of the bowel. Improvements in surgery have meant that many patients with rectal cancer can now undergo surgery that removes the rectum and avoids a permanent stoma. The operation that most patients have is an anterior resection of the rectum. Unfortunately this surgery frequently leads to a change in bowel function, with patients suffering from incontinence, urgency and unpredictability a problem known as anterior resection syndrome. These problems are believed to be fairly common following surgery but follow up appointments have traditionally concentrated on ensuring that the cancer has not returned and have not reviewed functional outcomes in enough detail. Because of this we are unsure exactly how common the problems described are. The proposed study will allow us to determine how many patients have ongoing symptoms following their surgery for rectal cancer. It will also allow us to use a newly developed scoring system the Low Anterior Resection Syndrome (LARS) score for the first time in a UK population, to ensure that it can accurately be used in the future to measure the problem and aid development of new therapies. An appreciation of the impact of symptoms on postoperative quality of life will encourage routine assessment of functional outcomes in clinical practice, allowing identification of patients who may benefit from treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,197

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2014

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 15, 2014

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

April 5, 2016

Status Verified

April 1, 2016

Enrollment Period

1.1 years

First QC Date

March 12, 2014

Last Update Submit

April 4, 2016

Conditions

Keywords

Rectal cancerAnterior Resection SyndromeFunctional outcomes

Outcome Measures

Primary Outcomes (1)

  • Number of participants with no LARS; minor LARS and major LARS

    This will allow us to determine the prevalence of Low Anterior Resection Syndrome

    At the time of questionnaire completion

Secondary Outcomes (1)

  • Correlation between LARS score and EORTC QLQ-C30 questionnaire score

    At the time of questionnaire completion

Other Outcomes (2)

  • LARS score in different age groups

    At time of questionnaire completion

  • LARS score in participants who have had laparoscopic surgery and participants who have had open surgery

    At time of questionnaire completion

Study Arms (1)

Anterior resection

Patients having had an anterior resection for rectal cancer who are more than 12 months post surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients having had an anterior resection for rectal cancer who are more than 12 months post surgery

You may qualify if:

  • Patients having had an anterior resection for rectal cancer who are more than 12 months post surgery
  • Patients who are more than 12 months post reversal of any defunctioning stoma
  • Aged over 18 years

You may not qualify if:

  • Presence of a stoma
  • Local recurrence of cancer
  • Current adjuvant therapy
  • Further rectal surgery after the initial operation
  • Insufficient written English to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Mary University of London

London, E1 2AT, United Kingdom

Location

MeSH Terms

Conditions

Rectal Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Mohamed Thaha, PhD FRCS

    Queen Mary University of London

    STUDY CHAIR

Study Design

Study Type
observational
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2014

First Posted

July 15, 2014

Study Start

May 1, 2014

Primary Completion

June 1, 2015

Study Completion

September 1, 2015

Last Updated

April 5, 2016

Record last verified: 2016-04

Locations